Skip to main content
. Author manuscript; available in PMC: 2012 Dec 26.
Published in final edited form as: J Immunol. 2011 Apr 15;186(10):6044–6055. doi: 10.4049/jimmunol.1004095

FIGURE 6.

FIGURE 6

Serum IgM level and number of peripheral CD27+ memory B cells are highly correlated with mean corrected T1 titer in NHL patients treated with rituximab-based chemotherapy. A, Table showing Spearman’s coefficients (ρ) and relative p values (P) for correlations among FACS parameters, serum Ig levels, and mean corrected T1 titers for influenza vaccine in all subjects (ALL), control group (CTR), and patients (PAT) groups. The corrected T1 titers for each strain are also shown for the patient group. *Number of B cells/μl; percentage of B cells in PBMCs; number of CD27+ memory B cells/μl; §percentage of CD27+ memory B cells in PBMCs; ||percentage of CD27+ memory B cells in B cells; mean corrected T1 titers for H3N2, H1N1, and B strains. B, Three-dimensional scatter plot of IgM serum level, mean corrected T1 titer, and number of peripheral CD27+ memory B cells. Intersections of the three vectors are represented in space as yellow spheres, connected to the three-dimensional regression plane (light purple surface) by lines representing least squares fitting.